Physician

Melih Ustaoglu, MD

According to 2025 Medicare claims, Melih Ustaoglu, MD (NPI: 1609405257) practices ophthalmology in the Terre Haute, IN market, with the plurality of this provider's patient population coming from Vigo, IN. This provider's primary affiliated billing organization is HIGHLAND RETINA ASSOCIATES, LLC (NPI: 1851840599; TIN: 813758844) and primary practice location at 47803-9303. Ustaoglu is affiliated with the IRCCO (ACO ID: A2619) and Central Florida ACO (ACO ID: A2801), participating under the MSSP model.

Ustaoglu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 478 traditional Medicare patients, billed 21,898 HCPCS/CPT codes, and received $925,850 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 290 prescription claims across 96 beneficiaries totaling $8,711 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 7 records totaling $156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$463K$926K2023 Medicare payment: $104,532 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $925,850 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023139887$104,532
202447821,898$925,850

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.4K$8.7K2023 Drug cost: $3,055 (USD; Tot_Drug_Cst)2024 Drug cost: $8,711 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20233284$3,055
202496290$8,711

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more214214$106
92014Established patient complete exam of visual system231306$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more244449$63
92134Imaging of retina4181,155$28
92250Photography of the retina188244$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate883,263$3,844
Ketorolac TromethamineKetorolac Tromethamine621,723$947
Brimonidine TartrateBrimonidine Tartrate171,101$881
MoxifloxacinMoxifloxacin Hcl25336$773
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat352,445$690

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$156Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Melih Ustaoglu, MD?

Tedicare shows public-source Medicare data for Melih Ustaoglu, MD (NPI 1609405257), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melih Ustaoglu, MD have ACO affiliation data?

Melih Ustaoglu, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and Central Florida ACO (MSSP, ACO ID A2801).

What billing organization is linked to Melih Ustaoglu, MD?

Melih Ustaoglu, MD is linked to HIGHLAND RETINA ASSOCIATES, LLC (billing NPI 1851840599) in the available physician profile data.

Does Melih Ustaoglu, MD have Open Payments data?

Melih Ustaoglu, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.